NCT07332000 2026-03-17A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecCandel Therapeutics, Inc.Phase 2 Recruiting45 enrolled
NCT02768363 2025-07-30Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)Candel Therapeutics, Inc.Phase 2 Active not recruiting187 enrolled